Steven Artandi, MD, PhD (@scidirector) 's Twitter Profile
Steven Artandi, MD, PhD

@scidirector

Stanford University medical oncologist and cancer scientist, and Director of the Stanford Cancer Institute. Follows and retweets are not endorsements.

ID: 1063242174408486912

linkhttp://cancer.stanford.edu calendar_today16-11-2018 01:27:43

1,1K Tweet

3,3K Followers

1,1K Following

Steven Artandi, MD, PhD (@scidirector) 's Twitter Profile Photo

I highly encourage learners from all levels to join our annual Comprehensive Cancer Research Training Program from 9/16 - 9/18. It is a unique, comprehensive introduction to the forefront of current #CancerResearch. Register today! stan.md/3yjKLvU #stanfordcancer

Steven Artandi, MD, PhD (@scidirector) 's Twitter Profile Photo

SCI member Michelle Monje🎗️ & others demonstrate that adaptive OPC responses are disrupted by #Neurofibromatosis (NF1) mutations in the neurogenetic disorder #NF1, which impairs oligodendroglial dynamics and results in motor learning deficits. go.nature.com/3LFQ6kp

Steven Artandi, MD, PhD (@scidirector) 's Twitter Profile Photo

SCI member Calvin Kuo and others higlight the potential of engineered matrices and patient-derived organoids for elucidating extracellular matrix contributions to human disease pathophysiology. stanford.io/4c6kGyu #PDAC

SCI member Calvin Kuo and others higlight the potential of engineered matrices and patient-derived organoids for elucidating extracellular matrix contributions to human disease pathophysiology. stanford.io/4c6kGyu #PDAC
Steven Artandi, MD, PhD (@scidirector) 's Twitter Profile Photo

SCI member Candice Thompson has joined the SCI-Office of Cancer Health Equity as the new medical director, focusing on engaging communities of color relating to breast cancer education, cancer care access and innovation, and clinical trial inclusion. Congratulations Candice N. Thompson, MD!

SCI member Candice Thompson has joined the SCI-Office of Cancer Health Equity as the new medical director, focusing on engaging communities of color relating to breast cancer education, cancer care access and innovation, and clinical trial inclusion. Congratulations <a href="/CTBreastMD/">Candice N. Thompson, MD</a>!
Steven Artandi, MD, PhD (@scidirector) 's Twitter Profile Photo

SCI member Kyle Loh and others demonstrate that artery endothelial cells form #HematopoieticStemCells in vivo and that hPSC-derived hematopoietic progenitors express core HSCmarkers HLF and HOXA5-10. bit.ly/3WJVVnb Ravi Majeti

SCI member Kyle Loh and others demonstrate that artery endothelial cells form #HematopoieticStemCells in vivo and that hPSC-derived hematopoietic progenitors express core HSCmarkers HLF and HOXA5-10. bit.ly/3WJVVnb <a href="/RaviMajetiMD/">Ravi Majeti</a>
Steven Artandi, MD, PhD (@scidirector) 's Twitter Profile Photo

SCI members Andrei Iagaru, Sandy Srinivas, James Brooks, and colleagues found 68Ga-RM2 PET–MRI showed better diagnostic performance than MRI alone in patients with biochemical recurrence of #ProstateCancer. bit.ly/3WBuKcO Sandy Srinivas

SCI members Andrei Iagaru, Sandy Srinivas, James Brooks, and colleagues found 68Ga-RM2 PET–MRI showed better diagnostic performance than MRI alone in patients with biochemical recurrence of #ProstateCancer. bit.ly/3WBuKcO <a href="/sandysrimd/">Sandy Srinivas</a>
Steven Artandi, MD, PhD (@scidirector) 's Twitter Profile Photo

SCI member Mark Buyyounouski & others detail recent updates to the National Comprehensive Cancer Network (NCCN) Guidelines for #BladderCancer, including changes in WHO Classifications, emerging tx options for #BacillusCalmetteGuérin unresponsive NMIB, and systemic therapy recommendations. bit.ly/3ysynKk

SCI member Mark Buyyounouski &amp; others detail recent updates to the <a href="/NCCN/">National Comprehensive Cancer Network (NCCN)</a> Guidelines for #BladderCancer, including changes in WHO Classifications, emerging tx options for #BacillusCalmetteGuérin unresponsive NMIB, and systemic therapy recommendations. bit.ly/3ysynKk
Steven Artandi, MD, PhD (@scidirector) 's Twitter Profile Photo

SCI member Wen-Kai Weng and others detail the pattern of post-#AutologousHematopoieticCell transplantation relapse and the management of relapsed disease using different therapeutic modalities. bit.ly/4dmIC28 #TcellLymphoma

SCI member Wen-Kai Weng and others detail the pattern of post-#AutologousHematopoieticCell transplantation relapse and the management of relapsed disease using different therapeutic modalities. bit.ly/4dmIC28 #TcellLymphoma
Steven Artandi, MD, PhD (@scidirector) 's Twitter Profile Photo

SCI members Adam de la Zerda, Kavita Sarin, and colleagues found that computer algorithms powered by artificial intelligence based on #DeepLearning can help healthcare practitioners diagnose #SkinCancers more accurately. bit.ly/46Lw5CB Adam de la Zerda

SCI members Adam de la Zerda, Kavita Sarin, and colleagues found that computer algorithms powered by artificial intelligence based on #DeepLearning can help healthcare practitioners diagnose #SkinCancers more accurately. bit.ly/46Lw5CB <a href="/adamdelazerda/">Adam de la Zerda</a>
Steven Artandi, MD, PhD (@scidirector) 's Twitter Profile Photo

SCI member Ansuman Satpathy & others provide insights into the dynamic remodeling of immune cells in the metastatic niche starting from early tumor development up to late-stage metastasis. bit.ly/3ArbTtX #BreastCancerMetastasis

SCI member Ansuman Satpathy &amp; others provide insights into the dynamic remodeling of immune cells in the metastatic niche starting from early tumor development up to late-stage metastasis. bit.ly/3ArbTtX #BreastCancerMetastasis
Steven Artandi, MD, PhD (@scidirector) 's Twitter Profile Photo

SCI member Natalie J. Torok & others showed that advanced glycation end-product-mediated structural changes enhance extracellular matrix viscoelasticity. Viscoelasticity can promote cancer progression independent of stiffness. go.nature.com/3X9klXl #HepatocellularCarcinoma

Steven Artandi, MD, PhD (@scidirector) 's Twitter Profile Photo

SCI members detail a method for cultivating patient-derived #lymphoma #organoids while maintaining the native FL TME demonstrating stability over 3 weeks, with consistent cellular composition, mutations, and gene expressions. bit.ly/4cvMzQx Ash Alizadeh, MD/PhD 🇺🇸 Max Diehn, MD/PhD

SCI members detail a method for cultivating patient-derived #lymphoma #organoids while maintaining the native FL TME demonstrating stability over 3 weeks, with consistent cellular composition, mutations, and gene expressions. bit.ly/4cvMzQx <a href="/AshAlizadeh/">Ash Alizadeh, MD/PhD 🇺🇸</a> <a href="/max_diehn/">Max Diehn, MD/PhD</a>
Steven Artandi, MD, PhD (@scidirector) 's Twitter Profile Photo

SCI member Allison Kurian and others found that many #BreastCancer survivors eligible for #GeneticCounseling and testing are not receiving it. However, among those who do test, nearly 2/3 who have a genetic variant are reaching out to family members. bit.ly/46YK6wS

SCI member <a href="/AllisonKurian/">Allison Kurian</a> and others found that many #BreastCancer survivors eligible for #GeneticCounseling and testing are not receiving it. However, among those who do test, nearly 2/3 who have a genetic variant are reaching out to family members. bit.ly/46YK6wS
Steven Artandi, MD, PhD (@scidirector) 's Twitter Profile Photo

SCI member James Brooks & others found active surveillance as an effective management strategy for patients diagnosed with favorable-risk #ProstateCancer. bit.ly/3yRYRoO

Steven Artandi, MD, PhD (@scidirector) 's Twitter Profile Photo

SCI member @Linda_Kachur & others around genome-wide PRS have the potential to enhance the detection of high-risk individuals and help distinguish between prognostic #glioma subtypes. bit.ly/3ABCPqI Melissa Bondy

Steven Artandi, MD, PhD (@scidirector) 's Twitter Profile Photo

SCI member Maria Roncarolo & others found that ICAM1 acts as an immune trigger, allowing T cell killing, and could play a role in #AcuteMyeloidLeukemia patient survival in vivo. Ravi Majeti go.nature.com/4g7vnnG

SCI member Maria Roncarolo &amp; others found that ICAM1 acts as an immune trigger, allowing T cell killing, and could play a role in #AcuteMyeloidLeukemia patient survival in vivo. <a href="/RaviMajetiMD/">Ravi Majeti</a> go.nature.com/4g7vnnG
Steven Artandi, MD, PhD (@scidirector) 's Twitter Profile Photo

The next round of the SCI Innovation Awards application is now open! The SCI supports projects focused on basic, translational, clinical, and population-based cancer research, as well as specific types of cancer. Apply today: stan.md/3ARppXW

Steven Artandi, MD, PhD (@scidirector) 's Twitter Profile Photo

Join our annual Comprehensive Cancer Research Training Program from 9/16 - 9/18! This unique event offers an introduction to cutting-edge #CancerResearch. Open to learners at all levels. Register now! stan.md/4eaY4hz #stanfordCancer

Join our annual Comprehensive Cancer Research Training Program from 9/16 - 9/18! This unique event offers an introduction to cutting-edge #CancerResearch. Open to learners at all levels. Register now! stan.md/4eaY4hz #stanfordCancer